US3453367A
(en)
*
|
1966-06-29 |
1969-07-01 |
Commercial Solvents Corp |
Methods for treating inflammation with estrogenic compounds
|
US3574235A
(en)
*
|
1967-06-06 |
1971-04-06 |
Commercial Solvents Corp |
Separation of mixture of diastereo-isomers of zearalanol
|
US3860616A
(en)
*
|
1969-05-01 |
1975-01-14 |
Merck & Co Inc |
Synthesis of d,1-zearalanol
|
US3697548A
(en)
*
|
1970-04-02 |
1972-10-10 |
Commercial Solvents Corp |
Zearalenone reduction
|
US3687982A
(en)
*
|
1971-03-09 |
1972-08-29 |
Commercial Solvents Corp |
Separation of mixed diastereoisomers of zearalanol
|
US3965274A
(en)
*
|
1972-07-20 |
1976-06-22 |
Commercial Solvents Corporation |
Method of preventing pregnancy with lactone derivatives
|
US3965275A
(en)
*
|
1974-02-11 |
1976-06-22 |
Commercial Solvents Corporation |
Composition and method
|
US4035504A
(en)
*
|
1975-05-12 |
1977-07-12 |
Imc Chemical Group, Inc. |
Method for treating cholesterolemia by administering resorcylic acid lactone derivatives
|
US4148808A
(en)
*
|
1975-08-22 |
1979-04-10 |
Int Minerals & Chem Corp |
Method for reducing zearalenone
|
US4010167A
(en)
*
|
1975-08-22 |
1977-03-01 |
Imc Chemical Group, Inc. |
Method for the recovery of zearalenone
|
DE2637972C2
(de)
*
|
1976-08-24 |
1986-03-20 |
Fishman, Avraham |
Schöpfkelle mit eingebauter Federwaage
|
US4069339A
(en)
*
|
1977-02-22 |
1978-01-17 |
American Cyanamid Company |
Novel method for the depression of fat deposition in swine
|
FR2388560A1
(fr)
*
|
1977-04-27 |
1978-11-24 |
Roussel Uclaf |
Nouvelles compositions zootechniques renfermant d'une part le zeranol et d'autre part un steroide 4,9,11 trienique
|
US4239772A
(en)
*
|
1979-05-30 |
1980-12-16 |
International Minerals & Chemical Corp. |
Allyl and propyl zearalenone derivatives and their use as growth promoting agents
|
US4409392A
(en)
*
|
1981-09-03 |
1983-10-11 |
International Minerals & Chemical Corp. |
6' Esters of zearalanol
|
US4443470A
(en)
*
|
1981-09-03 |
1984-04-17 |
International Minerals & Chemical Corp. |
Method of promoting growth and enhancing feed efficiency in meat producing animals
|
US4410512A
(en)
*
|
1981-12-28 |
1983-10-18 |
Beckman Instruments, Inc. |
Combinations having synergistic pituitary growth hormone releasing activity
|
FR2571372B1
(fr)
*
|
1984-07-25 |
1987-05-22 |
Panmedica Sa |
Procede de separation des diastereoisomeres du zearalanol
|
US4670249A
(en)
*
|
1985-04-12 |
1987-06-02 |
International Minerals & Chemical Corp. |
Growth-promoting compositions
|
US4690948A
(en)
*
|
1986-12-01 |
1987-09-01 |
International Minerals & Chemical Corp. |
Halogenated resorcylic acid lactone derivatives
|
US4751239A
(en)
*
|
1987-06-29 |
1988-06-14 |
International Minerals & Chemical Corp. |
6' Carbonate esters of zearalanol and its derivatives
|
US4778821A
(en)
*
|
1987-07-15 |
1988-10-18 |
International Minerals & Chemical Corp. |
Method for controlling helmintic parasites
|
EP0300325B1
(en)
*
|
1987-07-20 |
1993-06-16 |
COMETEC S.r.l. |
Compositions for promoting growth of animals
|
US4902711A
(en)
*
|
1988-01-19 |
1990-02-20 |
Pitman-Moore, Inc. |
6' Carbamate esters of zearalanol and its derivatives
|
IT1216059B
(it)
*
|
1988-03-11 |
1990-02-22 |
Crc Ricerca Chim |
Procedimento per la separazione di diastereomeri macrociclici.
|
US4886899A
(en)
*
|
1988-07-05 |
1989-12-12 |
Pitman-Moore, Inc. |
Housefly chemosterilants
|
US5206235A
(en)
*
|
1991-03-20 |
1993-04-27 |
Merck & Co., Inc. |
Benzo-fused lactams that promote the release of growth hormone
|
US5283241A
(en)
*
|
1992-08-28 |
1994-02-01 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5583130A
(en)
*
|
1992-09-25 |
1996-12-10 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5317017A
(en)
*
|
1992-09-30 |
1994-05-31 |
Merck & Co., Inc. |
N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release
|
US5284841A
(en)
*
|
1993-02-04 |
1994-02-08 |
Merck & Co., Inc. |
Benzo-fused lactams promote release of growth hormone
|
US5438136A
(en)
*
|
1993-11-02 |
1995-08-01 |
Merck & Co., Inc. |
Benzo-fused macrocycles promote release of growth hormone
|
US5494919A
(en)
*
|
1993-11-09 |
1996-02-27 |
Merck & Co., Inc. |
2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
US5492920A
(en)
*
|
1993-12-10 |
1996-02-20 |
Merck & Co., Inc. |
Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
|
US5492916A
(en)
*
|
1993-12-23 |
1996-02-20 |
Merck & Co., Inc. |
Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
US5721251A
(en)
*
|
1993-12-10 |
1998-02-24 |
Merck & Co., Inc. |
Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
|
US5606054A
(en)
*
|
1993-12-14 |
1997-02-25 |
Merck & Co., Inc. |
Heterocyclic-fused lactams promote release of growth hormone
|
US5721250A
(en)
*
|
1993-12-23 |
1998-02-24 |
Merck & Co. Inc. |
Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
|
WO1995034311A1
(en)
*
|
1994-06-13 |
1995-12-21 |
Merck & Co., Inc. |
Piperazine compounds promote release of growth hormone
|
US5656606A
(en)
*
|
1995-02-17 |
1997-08-12 |
Merck & Co., Inc. |
Camphor compounds promote release of growth hormone
|
US5731317A
(en)
*
|
1995-03-10 |
1998-03-24 |
Merck & Co., Inc. |
Bridged piperidines promote release of growth hormone
|
US5559128A
(en)
*
|
1995-04-18 |
1996-09-24 |
Merck & Co., Inc. |
3-substituted piperidines promote release of growth hormone
|
JP3133073B2
(ja)
*
|
1995-05-29 |
2001-02-05 |
ファイザー・インコーポレーテッド |
成長ホルモンの放出を促進するジペプチド類
|
CA2240186A1
(en)
|
1995-12-13 |
1997-06-19 |
Merck & Co., Inc. |
Assays for growth hormone secretagogue receptors
|
US6531314B1
(en)
|
1996-12-10 |
2003-03-11 |
Merck & Co., Inc. |
Growth hormone secretagogue receptor family
|
US6682908B1
(en)
|
1998-07-10 |
2004-01-27 |
Merck & Co., Inc. |
Mouse growth hormone secretagogue receptor
|
JP2002520011A
(ja)
|
1998-07-13 |
2002-07-09 |
メルク・アンド・カンパニー・インコーポレーテッド |
成長ホルモン分泌促進物質関連受容体および核酸
|
WO2000009538A2
(en)
|
1998-08-10 |
2000-02-24 |
Merck & Co., Inc. |
Canine growth hormone secretagogue receptor
|
US6380184B1
(en)
|
1998-10-28 |
2002-04-30 |
Bristol-Myers Squibb Co. |
Benzoazepines and analogs thereof useful as growth hormone secretagogues
|
US6498153B1
(en)
|
1998-12-31 |
2002-12-24 |
Akzo Nobel N.V. |
Extended release growth promoting two component composition
|
KR100699404B1
(ko)
|
1999-02-18 |
2007-03-23 |
가켄 세야쿠 가부시키가이샤 |
성장 호르몬 분비촉진제로서의 신규 아미드 유도체
|
US6518292B1
(en)
*
|
1999-03-12 |
2003-02-11 |
Bristol-Myers Squibb Co. |
Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
|
US6525203B1
(en)
|
1999-03-12 |
2003-02-25 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
US7645898B2
(en)
*
|
2000-08-24 |
2010-01-12 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and method of use thereof
|
US7919647B2
(en)
|
2000-08-24 |
2011-04-05 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7622503B2
(en)
|
2000-08-24 |
2009-11-24 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7855229B2
(en)
*
|
2000-08-24 |
2010-12-21 |
University Of Tennessee Research Foundation |
Treating wasting disorders with selective androgen receptor modulators
|
WO2003041643A2
(en)
*
|
2001-11-09 |
2003-05-22 |
Conforma Therapeutics Corporation |
Hsp90-inhibiting zearalanol compounds and methods of producing and using same
|
US8853266B2
(en)
*
|
2001-12-06 |
2014-10-07 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators for treating diabetes
|
US20070161608A1
(en)
*
|
2001-12-06 |
2007-07-12 |
Dalton James T |
Selective androgen receptor modulators for treating muscle wasting
|
US6831102B2
(en)
*
|
2001-12-07 |
2004-12-14 |
Bristol-Myers Squibb Company |
Phenyl naphthol ligands for thyroid hormone receptor
|
US20030199514A1
(en)
*
|
2002-03-27 |
2003-10-23 |
Fryburg David A. |
Methods for improving efficacy of treatment with growth hormone secretagogues
|
CA2482940A1
(en)
*
|
2002-04-17 |
2003-10-23 |
Taisho Pharmaceuticals Co., Ltd. |
Hair growth tonic
|
US6747048B2
(en)
|
2002-05-08 |
2004-06-08 |
Bristol-Myers Squibb Company |
Pyridine-based thyroid receptor ligands
|
US7405234B2
(en)
*
|
2002-05-17 |
2008-07-29 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
TW200407324A
(en)
*
|
2002-05-17 |
2004-05-16 |
Bristol Myers Squibb Co |
Bicyclic modulators of androgen receptor function
|
MY139563A
(en)
|
2002-09-04 |
2009-10-30 |
Bristol Myers Squibb Co |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
US7632858B2
(en)
*
|
2002-11-15 |
2009-12-15 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
US8309603B2
(en)
|
2004-06-07 |
2012-11-13 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US20040176425A1
(en)
*
|
2003-01-24 |
2004-09-09 |
Washburn William N. |
Cycloalkyl containing anilide ligands for the thyroid receptor
|
TW200504021A
(en)
*
|
2003-01-24 |
2005-02-01 |
Bristol Myers Squibb Co |
Substituted anilide ligands for the thyroid receptor
|
US20060148776A1
(en)
*
|
2003-03-13 |
2006-07-06 |
Conforma Therapeutics Corporation |
Drug formulations having long and medium chain triglycerides
|
US7557143B2
(en)
*
|
2003-04-18 |
2009-07-07 |
Bristol-Myers Squibb Company |
Thyroid receptor ligands
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
US7256208B2
(en)
*
|
2003-11-13 |
2007-08-14 |
Bristol-Myers Squibb Company |
Monocyclic N-Aryl hydantoin modulators of androgen receptor function
|
US7820702B2
(en)
|
2004-02-04 |
2010-10-26 |
Bristol-Myers Squibb Company |
Sulfonylpyrrolidine modulators of androgen receptor function and method
|
US20050182105A1
(en)
*
|
2004-02-04 |
2005-08-18 |
Nirschl Alexandra A. |
Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function
|
US7378426B2
(en)
|
2004-03-01 |
2008-05-27 |
Bristol-Myers Squibb Company |
Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
|
US7625923B2
(en)
|
2004-03-04 |
2009-12-01 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
US7388027B2
(en)
*
|
2004-03-04 |
2008-06-17 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
US7696241B2
(en)
|
2004-03-04 |
2010-04-13 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
US9884038B2
(en)
|
2004-06-07 |
2018-02-06 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator and methods of use thereof
|
US9889110B2
(en)
|
2004-06-07 |
2018-02-13 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator for treating hormone-related conditions
|
UA87854C2
(en)
|
2004-06-07 |
2009-08-25 |
Мерк Энд Ко., Инк. |
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
|
US20110237664A1
(en)
*
|
2004-06-07 |
2011-09-29 |
Dalton James T |
Selective androgen receptor modulators for treating diabetes
|
US8143425B2
(en)
*
|
2004-10-12 |
2012-03-27 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
CN101189006A
(zh)
*
|
2005-04-07 |
2008-05-28 |
康福玛医药公司 |
基于磷脂的药物制剂及其生产和使用方法
|
EP1931199A4
(en)
|
2005-08-31 |
2009-07-29 |
Univ Tennessee Res Foundation |
TREATMENT OF RENAL DISEASE, BURNS, INJURIES OR SPINAL CORD INJURY USING ANDROGEN RECEPTOR SELECTIVE MODULATORS
|
CA2631680A1
(en)
*
|
2005-12-01 |
2007-06-07 |
Conforma Therapeutics Corporation |
Compositions containing ansamycin
|
CU23558A1
(es)
|
2006-02-28 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
|
CA2658394C
(en)
|
2006-07-12 |
2016-08-16 |
University Of Tennessee Research Foundation |
Substituted acylanilides and methods of use thereof
|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
PT2583970E
(pt)
|
2006-08-02 |
2016-02-08 |
Cytokinetics Inc |
Certas entidades químicas, composições e métodos compreendendo imidazopirimidinas
|
US9844528B2
(en)
|
2006-08-24 |
2017-12-19 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US9730908B2
(en)
|
2006-08-24 |
2017-08-15 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
DK2054049T3
(en)
|
2006-08-24 |
2016-08-01 |
Univ Tennessee Res Found |
SUBSTITUTED ACYLANILIDES AND PROCEDURES FOR USING THEREOF
|
US10010521B2
(en)
|
2006-08-24 |
2018-07-03 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
ES2602789T3
(es)
|
2007-02-09 |
2017-02-22 |
Ocera Therapeutics, Inc. |
Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina
|
WO2008134828A2
(en)
|
2007-05-04 |
2008-11-13 |
Katholieke Universiteit Leuven |
Tissue degeneration protection
|
AU2008287421A1
(en)
*
|
2007-08-10 |
2009-02-19 |
Glaxosmithkline Llc |
Nitrogen containing bicyclic chemical entities for treating viral infections
|
US7968603B2
(en)
|
2007-09-11 |
2011-06-28 |
University Of Tennessee Research Foundation |
Solid forms of selective androgen receptor modulators
|
US8003689B2
(en)
*
|
2008-06-20 |
2011-08-23 |
Gtx, Inc. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
US20100204265A1
(en)
*
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
BRPI0921118B1
(pt)
|
2009-04-09 |
2019-04-09 |
Intervet International B.V. |
Método para fabricar zearalenol
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
EP2560488B1
(en)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
WO2013190520A2
(en)
|
2012-06-22 |
2013-12-27 |
The General Hospital Corporation |
Gh-releasing agents in the treatment of vascular stenosis and associated conditions
|
US9969683B2
(en)
|
2012-07-13 |
2018-05-15 |
Gtx, Inc. |
Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
|
US9744149B2
(en)
|
2012-07-13 |
2017-08-29 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
US9622992B2
(en)
|
2012-07-13 |
2017-04-18 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
US10258596B2
(en)
|
2012-07-13 |
2019-04-16 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
US10987334B2
(en)
|
2012-07-13 |
2021-04-27 |
University Of Tennessee Research Foundation |
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
|
KR102238970B1
(ko)
|
2012-07-13 |
2021-04-09 |
지티엑스, 인코포레이티드 |
선택적 안드로겐 수용체 조절자(sarms)를 이용한 안드로겐 수용체(ar) 양성 유방암의 치료 방법
|
US10314807B2
(en)
|
2012-07-13 |
2019-06-11 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
NZ707752A
(en)
|
2012-12-03 |
2020-01-31 |
Pfizer |
Novel selective androgen receptor modulators
|
US10092627B2
(en)
|
2013-04-08 |
2018-10-09 |
President And Fellows Of Harvard College |
Methods and compositions for rejuvenating skeletal muscle stem cells
|
WO2015181676A1
(en)
|
2014-05-30 |
2015-12-03 |
Pfizer Inc. |
Carbonitrile derivatives as selective androgen receptor modulators
|
EP3990447A1
(en)
|
2019-06-27 |
2022-05-04 |
Cytokinetics, Inc. |
Polymorphs of 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)methyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide
|
WO2023275715A1
(en)
|
2021-06-30 |
2023-01-05 |
Pfizer Inc. |
Metabolites of selective androgen receptor modulators
|